Evidence map›Paper›PMID 31091740›Full record

ReviewHigh-throughput2019

Emerging Technologies in Mass Spectrometry-Based DNA Adductomics.

Jingshu Guo, Robert J Turesky

Open access · goldAbstract readReview
In one paragraph

Review in High-throughput, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Novel Techniques for Mapping DNA Damage and Repair in the Brain.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Mass Spectral Library for DNA Adductomics.Chemical research in toxicology · 2024
    Article
  8. Article
  9. A Novel Adductomics Workflow IncorporatingEnvironmental science & technology · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. A Comprehensive Database for DNA Adductomics.Frontiers in chemistry · 2022
    Article
  18. Genome-wide mapping of genomic DNA damage: methods and implications.Cellular and molecular life sciences : CMLS · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jingshu GuoMasonic Cancer Center and Department of Medicinal Chemistry, University of Minnesota, 2231 6th St. SE, Minneapolis, MI 55455, USA. guoj@umn.edu.ORCID 0000-0001-8987-6911
Robert J TureskyMasonic Cancer Center and Department of Medicinal Chemistry, University of Minnesota, 2231 6th St. SE, Minneapolis, MI 55455, USA. rturesky@umn.edu.ORCID 0000-0001-7355-9903
University of Minnesota · US

Funding

Synthetic Approaches to Carcinogen-Linked OligonucleotidesP01CA160032 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 2012 to 2022
$14.0M
Chemical markers of heterocyclic aromatic amines for human biomonitoringR01CA122320 · NCI · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2007 to 2018
$4.8M
DNA adductomics of the urinary systemR01CA220367 · NCI · UNIVERSITY OF MINNESOTA · PI ROSENQUIST, THOMAS A, TURESKY, ROBERT J. · 2017 to 2022
$3.0M
New biomonitoring methodologies to measure DNA adducts in human tissuesR01ES019564 · NIEHS · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2011 to 2020
$2.8M
Carcinogen DNA adduct biomarkers in formalin fixed tissuesR33CA186795 · NCI · UNIVERSITY OF MINNESOTA · PI TURESKY, ROBERT J. · 2014 to 2016
$982k
NCI NIH HHS R01 CA122320NCI NIH HHS R01CA122320NCI NIH HHS R01CA160032NCI NIH HHS R01 CA220367NCI NIH HHS R01CA220367NCI NIH HHS R33CA186795NIEHS NIH HHS R01 ES019564NIEHS NIH HHS R01ES019564
6 · The paper itself

Abstract

The measurement of DNA adducts, the covalent modifications of DNA upon the exposure to the environmental and dietary genotoxicants and endogenously produced electrophiles, provides molecular evidence for DNA damage. With the recent improvements in the sensitivity and scanning speed of mass spectrometry (MS) instrumentation, particularly high-resolution MS, it is now feasible to screen for the totality of DNA damage in the human genome through DNA adductomics approaches. Several MS platforms have been used in DNA adductomic analysis, each of which has its strengths and limitations. The loss of 2'-deoxyribose from the modified nucleoside upon collision-induced dissociation is the main transition feature utilized in the screening of DNA adducts. Several advanced data-dependent and data-independent scanning techniques originated from proteomics and metabolomics have been tailored for DNA adductomics. The field of DNA adductomics is an emerging technology in human exposure assessment. As the analytical technology matures and bioinformatics tools become available for analysis of the MS data, DNA adductomics can advance our understanding about the role of chemical exposures in DNA damage and disease risk.

Indexed as

adductomicsCarcinogensDNA adductsmass spectrometry

Identifiers

PMID31091740
PMCPMC6630665
OpenAlexW2945008795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.